DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Juan Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: RNA Research Division, New England Biolabs, Inc., Beverly, MA 01915, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: New England Biolabs.
Abstract (Originalsprache)
The RNA-guided Cas9 endonuclease from Staphylococcus aureus (SauCas9) can catalyze multiple-turnover reactions whereas Cas9 from Streptococcus pyogenes (SpyCas9) is a single-turnover enzyme. Here we dissect the mechanism of multiple-turnover catalysis by SauCas9 and elucidate its molecular basis. We show that the multiple-turnover catalysis does not require more than stoichiometric RNA guides to Cas9 nuclease. Rather, the RNA-guide loaded ribonucleoprotein (RNP) is the reactive unity that is slowly released from product and recycled in the subsequent reaction. The mechanism that RNP is recycled for multiple-turnover reaction entails the unwinding of the RNA:DNA duplex in the R-loop. We argue that DNA rehybridization is required for RNP release by supplementing the energy cost in the process. Indeed, turnover is arrested when DNA rehybridization is suppressed. Further, under higher salt conditions, both SauCas9 and SpyCas9 showed increased turnover, and engineered SpyCas9 nucleases that form fewer direct or hydrogen bonding interactions with target DNA became multiple-turnover enzymes. Thus, these results indicate that for both SpyCas9 and SauCas9, turnover is determined by the energetic balance of the post-chemistry RNP-DNA interaction. Due to the conserved protein core folds, the mechanism underpinning turnover we establish here is likely operant in all Cas9 nucleases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RNA Research Division, New England Biolabs, Inc., Beverly, MA 01915, USA.
ORCID-Profile: Gregory Brett Robb
Förderung
- New England Biolabs
Zitieren
APA
Pan, J., Mabuchi, M., & Robb, G. B. (2023). DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad233
Vancouver
Pan J, Mabuchi M, Robb GB. DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad233
BibTeX
@article{Pan2023,
author = {Pan, Juan and Mabuchi, Megumu and Robb, Gregory Brett},
title = {DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad233}
}
EUVIMED